ERBB2 and neoplasm: The distribution of the PAM50 intrinsic subtype in primary tumor versus PLN was 25% versus 0% for normal, 25% versus 8% for luminal A, 21% versus 46% for luminal B, 17% versus 29% for HER2-E and 12% versus 17% for basal-like tumors (Figure 1C).